BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 23201377)

  • 1. Re: mifepristone inhibits GRβ coupled prostate cancer cell proliferation.
    Kapoor S
    J Urol; 2013 May; 189(5):1993-4. PubMed ID: 23201377
    [No Abstract]   [Full Text] [Related]  

  • 2. Mifepristone inhibits GRβ coupled prostate cancer cell proliferation.
    Ligr M; Li Y; Logan SK; Taneja S; Melamed J; Lepor H; Garabedian MJ; Lee P
    J Urol; 2012 Sep; 188(3):981-8. PubMed ID: 22819113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brief treatment with the glucocorticoid receptor antagonist mifepristone normalizes the reduction in neurogenesis after chronic stress.
    Oomen CA; Mayer JL; de Kloet ER; Joëls M; Lucassen PJ
    Eur J Neurosci; 2007 Dec; 26(12):3395-401. PubMed ID: 18052970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the glucocorticoid receptor results in an enhanced miR-99a/100-mediated radiation response in stem-like cells from human prostate cancers.
    Rane JK; Erb HH; Nappo G; Mann VM; Simms MS; Collins AT; Visakorpi T; Maitland NJ
    Oncotarget; 2016 Aug; 7(32):51965-51980. PubMed ID: 27340920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Induction of apoptosis by mifepristone in androgen-independent prostate cancer cell lines in vitro].
    Zhang H; Lü JJ; Gao QZ; Zhang J
    Zhonghua Wai Ke Za Zhi; 2006 Mar; 44(6):382-5. PubMed ID: 16638347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brief treatment with the glucocorticoid receptor antagonist mifepristone normalises the corticosterone-induced reduction of adult hippocampal neurogenesis.
    Mayer JL; Klumpers L; Maslam S; de Kloet ER; Joëls M; Lucassen PJ
    J Neuroendocrinol; 2006 Aug; 18(8):629-31. PubMed ID: 16867184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is mifepristone useful in psychotic depression?
    Carroll BJ; Rubin RT
    Neuropsychopharmacology; 2006 Dec; 31(12):2793-4; author reply 2795-7. PubMed ID: 17109015
    [No Abstract]   [Full Text] [Related]  

  • 8. Cytostasis and morphological changes induced by mifepristone in human metastatic cancer cells involve cytoskeletal filamentous actin reorganization and impairment of cell adhesion dynamics.
    Brandhagen BN; Tieszen CR; Ulmer TM; Tracy MS; Goyeneche AA; Telleria CM
    BMC Cancer; 2013 Jan; 13():35. PubMed ID: 23351358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mifepristone prevents the expression of long-term behavioural sensitization to amphetamine.
    De Vries TJ; Schoffelmeer AN; Tjon GH; Nestby P; Mulder AH; Vanderschuren LJ
    Eur J Pharmacol; 1996 Jun; 307(2):R3-4. PubMed ID: 8832229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of the new glucocorticoid receptor antagonist ORG 34517 and RU486 (mifepristone) on glucocorticoid receptor nuclear translocation in the AtT20 cell line.
    Peeters BW; Ruigt GS; Craighead M; Kitchener P
    Ann N Y Acad Sci; 2008 Dec; 1148():536-41. PubMed ID: 19120154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FKBP5 mRNA Expression Is a Biomarker for GR Antagonism.
    Bali U; Phillips T; Hunt H; Unitt J
    J Clin Endocrinol Metab; 2016 Nov; 101(11):4305-4312. PubMed ID: 27459525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of a C-glucuronide as a liver targeting group: conjugate of a glucocorticoid antagonist.
    Sorensen BK; Link JT; von Geldern T; Emery M; Wang J; Hickman B; Grynfarb M; Goos-Nilsson A; Carroll S
    Bioorg Med Chem Lett; 2003 Jul; 13(14):2307-10. PubMed ID: 12824023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antiglucocorticoid action of mifepristone.
    Agarwai MK
    Pharmacol Ther; 1996; 70(3):183-213. PubMed ID: 8888066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic and Nongenomic Effects of Mifepristone at the Cardiovascular Level: A Review.
    Feiteiro J; Mariana M; Verde I; Cairrão E
    Reprod Sci; 2017 Jul; 24(7):976-988. PubMed ID: 27678094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The glucocorticoid receptor antagonist mifepristone reduces ethanol intake in rats under limited access conditions.
    Koenig HN; Olive MF
    Psychoneuroendocrinology; 2004 Sep; 29(8):999-1003. PubMed ID: 15219650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metyrapone and mifepristone reverse recognition memory loss induced by spontaneous morphine withdrawal in mice.
    Mesripour A; Hajhashemi V; Rabbani M
    Basic Clin Pharmacol Toxicol; 2008 Apr; 102(4):377-81. PubMed ID: 18341515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid mechanisms may contribute to ECT-induced retrograde amnesia.
    Nagaraja N; Andrade C; Sudha S; Madan Singh N; Chandra JS; Venkataraman BV
    Psychopharmacology (Berl); 2007 Jan; 190(1):73-80. PubMed ID: 17072590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyethylene glycol but not mifepristone prevents intestinal lymphocyte loss following treadmill exercise in mice.
    Quadrilatero J; Guan J; Boudreau J; Marra S; Hoffman-Goetz L
    Acta Physiol Scand; 2005 Feb; 183(2):201-9. PubMed ID: 15676061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulsatile Cortisol Feedback on ACTH Secretion Is Mediated by the Glucocorticoid Receptor and Modulated by Gender.
    Roelfsema F; Aoun P; Veldhuis JD
    J Clin Endocrinol Metab; 2016 Nov; 101(11):4094-4102. PubMed ID: 27548106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progesterone receptor antagonist therapy has therapeutic potential even in cancer restricted to males as evidenced from murine testicular and prostate cancer studies.
    Check JH; Dix E; Wilson C; Check D
    Anticancer Res; 2010 Dec; 30(12):4921-3. PubMed ID: 21187471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.